Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 3985082 | 10 pages | https://doi.org/10.1155/2018/3985082

Induction of Apoptosis and Inhibition of Epithelial Mesenchymal Transition by α-Mangostin in MG-63 Cell Lines

Academic Editor: Jae Youl Cho
Received31 Jan 2018
Revised04 Apr 2018
Accepted05 Apr 2018
Published26 Apr 2018

Abstract

Osteosarcoma is the most common bone primary malignant tumor and nearly 30% of patients still die from osteosarcoma due to metastasis or recurrence. Thus, it is necessary to develop effective new chemotherapeutic agents for osteosarcoma treatment. α-Mangostin is a xanthone derivative shown to have antioxidant and anticarcinogen properties. However, the molecular mechanisms underlying the antimetastatic effects of osteosarcoma remain unclear. In metastasis progression, epithelial mesenchymal transition (EMT) is a process that plays important roles in development, cell polarity, and increased invasion and migration. This study focused on the induction of apoptosis and inhibition of EMT process by α-mangostin in human osteosarcoma cell line MG63. α-Mangostin treatments on MG63 cells not only showed the several lines of evidence of apoptotic cell death but also inhibited cell migration, invasion, and EMT-inducing transcription factor. In conclusion, we demonstrate that the α-mangostin induces apoptosis via mitochondrial pathway and suppresses metastasis of osteosarcoma cells by inhibiting EMT.

1. Introduction

Osteosarcoma, which is highly malignant and the most common bone tumor, predominates among teenagers. Although its prevalence is low relative to other cancers, it is fatal if not discovered early [1]. It has several characteristics, including a rapid cell growth rate, high metastatic potential, and local infiltration to other organs [2, 3]. Despite various treatments such as surgery, radiotherapy, and chemotherapy, the five-year survival rates of osteosarcoma patients are still problematic [4]. Due to local invasion, lymphatic spreading, and metastasis, the cancer prognosis is usually poor. Regarding the management of osteosarcoma, the primary problem is the inability to control local metastasis [5]. Hence, it is necessary to find effective new therapeutic agents without side effects. In recent years, natural substances for the prevention and management of cancers have received much attention due to their limited toxicity and multiple bioactivities [6].

The purple mangosteen (Garcinia mangostana) is a tropical tree native to Asian countries such as India, the Philippines, Malaysia, and Thailand [7]. The mangosteen pericarp, used as a traditional medicine for many diseases, contains many compounds known as xanthones [8, 9]. Xanthones are associated with a variety of biological activities: cardioprotective [10], anti-inflammatory [11, 12], antibacterial [13], and antioxidant [14]. α-Mangostin, one of the xanthones, has demonstrated anticancer activity against various cancer cell lines [7, 1518]. In our previous studies, α-mangostin induced significant cell death through apoptosis and cell cycle arrest in oral squamous cell carcinoma cell lines [19]. However, the effects of α-mangostin against osteosarcoma cells are completely unknown.

During cancer progression and metastasis, a cell morphologic conversion process occurs known as an epithelial mesenchymal transition, which is a significant action. EMT is a cellular process that allows polarized epithelial cells, which interact with basal surface membranes, to transform nonpolarized and invasive mesenchymal cells [20]. EMT is characterized by cell adhesion loss, down-regulation of E-cadherin (epithelial molecule), and upregulation of N-cadherin (mesenchymal molecules) [21, 22].

The current study was designed to elucidate the effect of α-mangostin on MG-63 osteosarcoma cell apoptosis, EMT, and the molecular mechanism.

2. Materials and Methods

2.1. Reagents

The following reagents were obtained commercially. α-Mangostin was purchased from Chromadex (Irvine, CA, USA). Fetal bovine serum (FBS) and Dulbecco Modified Eagle Medium (DMEM) were obtained from Thermo Fisher Scientific (Pittsburgh, PA, USA). 3-[4,5-Dimethylthiazol-2-yl]2,5-diphenyl tetrazolium bromide (MTT) and dimethyl sulfoxide (DMSO) were purchased from DUCHEFA Biochem (Haarlem, The Netherlands). Insert-type transwell permeable supports were obtained from Corning (Kennebunk, ME, USA). Antibodies against caspase-3, cleaved caspase-3, PARP, E-cadherin, slug, snail, ERK, phospho ERK, JNK, phosphor JNK, p38, and phosphor p38 were purchased from Cell Signaling Technology (Beverly, MA, USA). Bcl-2, Bak, caspase-9, caspase-7, N-cadherin, and β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse anti-actin antibody, mouse anti-rabbit IgG antibody, and rabbit anti-mouse IgG antibodies were obtained from Enzo Biochem (Farmingdale, NY, USA).

2.2. Cell Culture and α-Mangostin Treatment

The human osteosarcoma cell line MG-63 was purchased from ATCC (Rockville, MD, USA). Cells were maintained at 37°C in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin (GIBCO-BRL, Rockville, MD, USA). α-Mangostin was dissolved in dimethyl sulfoxide (DMSO) at a stock solution of 20 mM and was kept frozen at −20°C until use. The stock was diluted to their concentration with DMEM when needed. Prior to α-mangostin treatment, cells were grown to about 70%–80% confluence and then exposed to α-mangostin at different concentrations (0–50 μM) for 24–72 h. Cells grown in a medium containing an equivalent amount of DMSO without α-mangostin served as controls.

2.3. Cell Cytotoxicity Assay

The cell viability of α-mangostin was assessed using an MTT assay. MG-63 cells were seeded in a 96-well plate and treated with α-mangostin at various concentrations (0–40 μM) for 24–72 h. And then the cells were treated with MTT stock solution and incubated at 37°C with 5% CO2 for 4 h. After that, the MTT solution was removed and DMSO was added to each well. The absorbance was recorded on a microplate reader (Tecan, Männedorf, Switzerland) at a wavelength of 620 nm.

2.4. Hoechst Staining

MG-63 cells were seeded in a 60 mm culture dish at a density of 3 105 cells/dish and treated with 10–50 μM α-mangostin for 24 h. The cells were washed with phosphate buffered saline (PBS) and fixed in a 4% paraformaldehyde (PFA) solution for 10 min. After fixation, the cells were washed again and stained with 1 μg/ml Hoechst 33342 for 10 min at 37°C chamber. Finally, the slides were mounted with glycerol. Each sample was observed under an epifluorescence microscope (Axioskop, Carl Zeiss, Göttingen, Germany).

2.5. Flow Cytometry

MG-63 cells were seeded in a 60 mm culture dish at a density of 3 105 cells/dish and treated with 10–50 μM α-mangostin for 24 h. The harvested cells were washed with PBS containing 1% bovine serum albumin and fixed 95% ethanol with 0.5% Tween 20 to a final concentration of 70% ethanol. The cells were then stained with 10 μg/ml propidium iodide (PI) in 1 ml PBS containing 50 μg/ml RNase A (Invitrogen, Carlsbad, CA, USA) at 4°C for 30 min. Finally, the cells were measured using a CYTOMICS FC500 flow cytometry system (Beckman Coulter, FL, CA, USA). MG-63 cells were seeded in a 60 mm culture dish at a density of 3 × 105 cells/dish. After treatment, the cells were washed with phosphate buffered saline (PBS) and 1 mg/ml of JC-1 was added directly to the cell culture medium. The analysis of MMP was measured on a CYTOMICS FC500 flow cytometry system (Beckman Coulter, FL, CA, USA). Data was analyzed using CXP software, version 2.2.

2.6. Invasion and Migration Assay

A cell invasion assay (transwell assay) and a migration assay were conducted to examine the capacity of cell invasion and migration, as described previously. A transwell with an 8.0 μm pore polycarbonate membrane (Corning Costar, Cambridge, MA, USA) was coated with 40 μl Matrigel at 200 μg/ml and incubated for 2 h. Next, MG-63 cells were seeded and treated with 10–25 μM α-mangostin. The upper chamber of the transwell was filled with serum-free medium and the lower chamber with 800 μl medium containing 10% FBS for 48 h of incubation at 37°C in a humidified 5% CO2 atmosphere. The cells were fixed in methanol and stained with hematoxylin for 30 min and were then counted under an inverted microscope (Olympus, Tokyo, Japan).

2.7. Western Blot Analysis

MG-63 cells were lysed in RIPA buffer (Cell Signaling; Danvers, MA) at 4°C for 1 h, which includes pH 7.6 50 mM Tris-Cl, 300 mM NaCl, 0.5% Triton X-100, 2 μl/ml aprotinin, 2 mM PMSF, and 2 μl/ml leupeptin. Total cellular proteins (25–30 μg) in the cell lysate were separated by 10% SDS polyacrylamide gel electrophoresis and the proteins on the gel were then transferred onto a membrane. The membranes were blocked with skim milk blocking buffer for 2 h at room temperature. After blocking, the membranes were kept in a 4°C refrigerator for 24 h with the respective primary antibodies. The next day the membranes were treated with secondary antibodies for 2 h at room temperature. Protein bands were exposed to Alpha Imager HP (Alpha Innotech, Santa Clara, CA, USA). Bcl-2, Bak, caspase-9, 7, 3, cleaved caspase-3, PARP, E-cadherin, N-cadherin, slug, snail, and β-actin were used as the primary antibodies, while anti-rabbit and anti-mouse antibodies were used as the secondary antibodies.

2.8. Real-Time RT-PCR

Gene expression was analyzed with real-time reverse transcription-polymerase chain reaction (RT-PCR). Total RNA was isolated from MG-63 cells using a RNeasy Mini Kit (Qiagen, Hilden, DEU). Total RNA concentration was determined with a NanoDrop 2.0 spectrophotometer (Thermo Fisher Scientific, Pittsburgh, PA, USA), and 2 μg total RNA was reversibly transcribed into cDNA for 5 min at 70°C using a M-MLV cDNA Synthesis Kit (Enzynomics, Dajeon, KOR). PCR was performed using the TOPreal™ qPCR 2X PreMIX (Enzynomics, Dajeon, KOR) and run on an ABI 7500 Fast Real-Time PCR System (Applied Biosystems 7500 System, Foster City, CA, USA; using Sequence Detection System software version 2.0.1). The relative mRNA levels were normalized using GAPDH as a housekeeping gene.

2.9. Statistical Analysis

Reported data represent mean ± SE. Statistical significance between groups was analyzed using one-way analysis of variance (ANOVA) and Dunnett’s comparison. Differences with probability values < 0.05 were considered statistically significant.

3. Results

3.1. α-Mangostin Affected Cell Viability and Induce Apoptosis in MG-63 Cells

MG-63 cells were incubated with α-mangostin (0–40 μM) for 24, 48, and 72 h and cell viability was assessed with an MTT assay. The result showed that α-mangostin decreased the viability of MG-63 cells with the best concentration of cell death at 40 μM (Figure 1). Whether α-mangostin-induced cell death is associated with apoptosis, we investigated nuclear condensation and an increase in the sub-G1 ratio in the cell cycle, which are hallmarks of apoptosis. Cells were treated with the indicated concentration of α-mangostin for 24 h, and Hoechst staining was performed. As shown in Figures 2(a) and 2(b), nontreated group cells showed typically round nuclei, whereas, α-mangostin-treated group cells showed condensed nuclei in a dose-dependent manner. To investigate the proportion of sub-G1 fraction in MG-63 cells, PI (propidium iodide) staining and flow cytometry analysis were performed. Compared to the control group, α-mangostin-treated cells showed an increase in PI positive cells (Figure 2(c)). These results indicated that α-mangostin induced apoptosis of MG-63 cells significantly 50 μM α-mangostin for 24 h.

3.2. α-Mangostin-Induced Apoptosis via Mitochondrial Pathway in MG-63 Cells

The mitochondrial pathway of apoptosis induced mitochondrial dysfunction through mitochondrial membrane potential loss [23, 24]. To investigate the effects of α-mangostin on mitochondria, we examined various features related to mitochondrial activity after α-mangostin treatment for 24 h. Bcl-2 family proteins are associated with mitochondrial membrane; we investigated the expression of Bcl-2 and Bak. The expression level of Bcl-2 decreased, whereas Bak expression increased in a dose-dependent manner (Figure 3(a)). To evaluate the MMP of MG-63 cells were stained with JC-1 and labeled green or red fluorescence. The relative ratio of green to red fluorescence was significantly increased in experimental groups, suggesting that α-mangostin caused MMP in MG-63 cells to collapse (Figure 3(b)). The loss of MMT results in the translocation of cytochrome c from mitochondria into cytosol [25]. As shown in Figure 3(c), treatment with α-mangostin 25 μM significantly increased the release of cytochrome c into the cytosol. Also, caspase is well known as a key protein in the mitochondrial pathway of apoptosis. The protein expression of caspase-9, -7, -3, and PARP was investigated by western blot. The procaspase-9, -7, and -3 and PARP were downregulated dose-dependently, while on the other hand, cleaved caspase-3 and cleaved PARP were strongly upregulated at 50 μM α-mangostin (Figure 4). This data suggested that α-mangostin-induced apoptosis is triggered by mitochondrial dysfunction and caspase cascade activation.

3.3. α-Mangostin Inhibited Invasion and Migration through Suppression EMT in MG-63 Cells

Inhibition of cell migration and invasion prevents cancer metastasis into other organs [26]. To elucidate the effect of α-mangostin on MG-63 EMT, transwell migration and invasion assay were performed. Cells were exposed to α-mangostin (0, 10, and 25 μM) for 48 h; we observed a significant reduction in the migratory capacity of cells compared to the control (Figures 5(a) and 5(c)). Moreover, the invasive capability of MG63 cells was also suppressed by α-mangostin treatment (Figures 5(b) and 5(d)). In addition, EMT was closely associated with tumor migration and invasion, to evaluate the effects of α-mangostin on EMT-related marker protein expression such as E-cadherin, N-cadherin, slug, and snail. Western blot data showed that α-mangostin significantly increased E-cadherin, which is an epithelial marker, whereas mesenchymal markers, including N-cadherin, slug, and snail, decreased in a dose-dependent manner (Figures 6(a) and 6(b)). To further characterize the mRNA expression level of EMT-related gene, we examined the real-time RT-PCR. The result showed that α-mangostin decreased the mRNA expression of occludin and increased the mRNA expression of fibronectin (Figures 6(c) and 6(d)). These results implied that α-mangostin inhibited MG-63 cell migration and invasion through the upregulation of epithelial markers and downregulation of mesenchymal markers.

3.4. α-Mangostin Suppressed the Phosphorylation of MAPK Pathways in MG-63 Cells

Members of the mitogen-activated protein kinase (MAPK) family consist of ERK1/2, JNK, and p38 and play important roles in cell apoptosis and migration [27]. Thus, in order to investigate whether α-mangostin-induced apoptosis and EMT inhibition are associated with MAPK pathways, we verified the protein expressions of MAPK signaling. As shown in Figure 7, phosphorylation of ERK1/2 and p38 expressions were downregulated by 10 μM α-mangostin in a time-dependent manner. However, the phosphorylation form of JNK was not detected by western blot. This data demonstrated that 10 μM of α-mangostin, which is a concentration of EMT suppression, inhibited MAPK, signaling activation.

4. Discussion

The pericarp of mangosteen is an abundant source of polyphenolic compounds, including xanthones. There are three types of xanthone derivatives: α-mangostin, β-mangostin, and γ-mangostin; out of these, α-mangostin has been recognized as the most potent xanthone and, as a result, has attracted the most interest due to its properties [7, 28]. In our previous study, α-mangostin was demonstrated to have a potent anticancer effect in human oral squamous cell carcinoma cell lines (OSCC) through apoptosis and cell cycle arrest [19]. Also, α-mangostin has been reported to inhibit migration and invasion in various cancer cells, including melanoma cells, pancreatic cancer cells, and lung adenocarcinoma cells [17, 2931]. However, the effect of α-mangostin on human osteosarcoma cells is uncertain. Therefore, our study investigated the anticancer effects of α-mangostin on human osteosarcoma MG-63 cells. Induction of apoptosis is a well-known regulation method in cancer treatment. Apoptosis is a type I programmed cell death characterized by cell shrinkage, nuclear condensation, and accumulation of sub-G1 [32]. In our study, we found that α-mangostin induced nuclear condensation and an increase in the proportion of sub-G1. The intrinsic pathway of apoptosis is mediated with mitochondria membrane permeability loss caused by the destruction of the outer mitochondrial membrane and the release of proapoptotic proteins [33]. Bcl-2 family proteins are critical controllers of the mitochondria; these proteins are divided into antiapoptotic proteins and proapoptotic proteins [34]. Bcl-2 is the typical antiapoptotic protein in the mitochondrial membrane, while Bak is expressed in the cytosol. When apoptosis occurs, Bak is translocated into the mitochondrial membrane and induces mitochondrial dysfunction and subsequently cytochrome c is released from mitochondria into cytoplasm [35]. Along with the Bcl-2 family, the caspase family are regarded as regulators of apoptosis. Caspases are categorized into initiators, including caspase-2, -8, and -9, and effectors, including caspase-3, -6, and -7 [36]. In this study, mitochondrial membrane potential loss, Bcl-2 down-regulation and Bak upregulation, cytochrome c, which promotes formation of apoptosome translocation, and caspase activation are detected by treating α-mangostin, suggesting that α-mangostin-induced apoptosis is related to the mitochondrial pathway and the caspase cascade.

EMT is important for tumor invasion and the metastasis process [37, 38]. During EMT, primary site epithelial cells undergo morphological and genetic alterations that take on a mesenchymal character, resulting in secondary tumor formation at another site [39, 40]. Thus, controlling of EMT is considered a promising approach to the inhibition of metastasis. In the present study, we found that α-mangostin reduced MG-63 cell migration and invasion capability through regulation of EMT-related marker protein expressions. E-cadherin expression, which is an epithelial marker, increased while N-cadherin expression, which is a mesenchymal marker, decreased dose-dependently. Transcription factors, slug and snail protein, and mRNA expressions also decreased after being treated with α-mangostin. The MAPK pathway is upstream intracellular signaling and regulates the various cellular processes, including apoptosis and cell migration and invasion [41, 42]. Chen et al. reported that α-mangostin suppressed renal carcinoma cell metastasis by ERK expression [43]. Expressions of MAPK family proteins (ERK1/2, JNK, and p38) in this study and phosphorylation of ERK1/2 and p38 decreased in a time-dependent manner. JNK phosphorylation expression was not detected by western blot. Our results suggest that α-mangostin induced apoptosis through the mitochondrial pathway and reduced cell migration and invasion through EMT inhibition. Also, α-mangostin stimulated MAPK pathway activation in human osteosarcoma MG-63 cells.

This study has several limitations as the experimental concentrations of α-mangostin used in in vitro data may not be confirmed through an in vivo study. In addition, it is difficult to investigate the cytotoxic effect in various normal cells. α-Mangostin-stimulated MAPK signaling action was not confirmed by MAPK inhibitors during the apoptosis and EMT inhibition processes.

5. Conclusions

The present study demonstrated the molecular mechanisms underlying the chemotherapeutic properties of α-mangostin on human osteosarcoma MG-63 cells and showed the valuable data for the development of a novel anticancer agent.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

Sung-Jin Park, Hye-Jin Kim, Bong-Soo Park, and In-Ryoung Kim conceived and designed the experiments; Su-Bin Yu and Hae-Mi Kang performed the experiments; Bong-Soo Park and In-Ryoung Kim analyzed the data; In-Ryoung Kim contributed reagents/materials/analysis tools; Sung-Jin Park, Su-Bin Yu, Bong-Soo Park, and In-Ryoung Kim wrote the paper. Sung-Jin Park and Bong-Soo Park contributed equally to this study.

Acknowledgments

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (no. NRF-2017R1C1B5018034).

References

  1. M. L. Broadhead, J. C. M. Clark, D. E. Myers, C. R. Dass, and P. F. M. Choong, “The molecular pathogenesis of osteosarcoma: a review,” Sarcoma, vol. 2011, Article ID 959248, 12 pages, 2011. View at: Publisher Site | Google Scholar
  2. M. G. Pridgeon, P. J. Grohar, M. R. Steensma, and B. O. Williams, “Wnt signaling in ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors,” Current Osteoporosis Reports, vol. 15, no. 4, pp. 239–246, 2017. View at: Publisher Site | Google Scholar
  3. L. Wang and G.-B. Xue, “Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis,” Biochemical and Biophysical Research Communications, vol. 495, no. 1, pp. 27–34, 2018. View at: Publisher Site | Google Scholar
  4. F. Lamoureux, M. Baud'huin, B. Ory et al., “Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma,” Oncotarget , vol. 5, no. 17, pp. 7805–7819, 2014. View at: Publisher Site | Google Scholar
  5. A. Krajarng, S. Nilwarankoon, S. Suksamrarn, and R. Watanapokasin, “Antiproliferative effect of α-mangostin on canine osteosarcoma cells,” Research in Veterinary Science, vol. 93, no. 2, pp. 788–794, 2012. View at: Publisher Site | Google Scholar
  6. B. Vue, S. Zhang, and Q.-H. Chen, “Synergistic effects of dietary natural products as anti-prostate cancer agents,” Natural Product Communications (NPC), vol. 10, no. 12, pp. 2179–2188, 2015. View at: Google Scholar
  7. J. J. Johnson, S. M. Petiwala, D. N. Syed et al., “α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth,” Carcinogenesis, vol. 33, no. 2, pp. 413–419, 2012. View at: Publisher Site | Google Scholar
  8. R. Kaomongkolgit, “Alpha-mangostin suppresses MMP-2 and MMP-9 expression in head and neck squamous carcinoma cells,” Odontology, vol. 101, no. 2, pp. 227–232, 2013. View at: Publisher Site | Google Scholar
  9. A. Sato, H. Fujiwara, H. Oku, K. Ishiguro, and Y. Ohizumi, “α-Mangostin induces Ca2+-ATPase-dependent apoptosis via mitochondrial pathway in PC12 cells,” Journal of Pharmacological Sciences, vol. 95, no. 1, pp. 33–40, 2004. View at: Publisher Site | Google Scholar
  10. P. D. Sampath and K. Vijayaraghavan, “Cardioprotective effect of α-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats,” Journal of Biochemical and Molecular Toxicology, vol. 21, no. 6, pp. 336–339, 2007. View at: Publisher Site | Google Scholar
  11. M. T. Chomnawang, S. Surassmo, V. S. Nukoolkarn, and W. Gritsanapan, “Effect of Garcinia mangostana on inflammation caused by Propionibacterium acnes,” Fitoterapia, vol. 78, no. 6, pp. 401–408, 2007. View at: Publisher Site | Google Scholar
  12. L.-G. Chen, L.-L. Yang, and C.-C. Wang, “Anti-inflammatory activity of mangostins from Garcinia mangostana,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 688–693, 2008. View at: Publisher Site | Google Scholar
  13. H. Z. Asfour, “Antimicrobial and quorum sensing inhibitory activities of the pericarp of Garcinia mangostana,” Pakistan Journal of Pharmaceutical Sciences, vol. 29, supplement 4, pp. 1353–1357, 2016. View at: Google Scholar
  14. M. M. Mackeen, A. M. Ali, N. H. Lajis et al., “Antimicrobial, antioxidant, antitumour-promoting and cytotoxic activities of different plant part extracts of Garcinia atroviridis Griff. ex T. anders,” Journal of Ethnopharmacology, vol. 72, no. 3, pp. 395–402, 2000. View at: Publisher Site | Google Scholar
  15. M.-A. Shibata, M. Iinuma, J. Morimoto et al., “α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation,” BMC Medicine, vol. 9, article 69, 2011. View at: Publisher Site | Google Scholar
  16. R. Kaomongkolgit, N. Chaisomboon, and P. Pavasant, “Apoptotic effect of alpha-mangostin on head and neck squamous carcinoma cells,” Archives of Oral Biolog, vol. 56, no. 5, pp. 483–490, 2011. View at: Publisher Site | Google Scholar
  17. Q. Xu, J. Ma, J. Lei et al., “α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway,” BioMed Research International, vol. 2014, Article ID 546353, 12 pages, 2014. View at: Publisher Site | Google Scholar
  18. S.-C. Hsieh, M.-H. Huang, C.-W. Cheng, J.-H. Hung, S.-F. Yang, and Y.-H. Hsieh, “α-mangostin induces mitochondrial dependent apoptosis in human hepatoma SK-Hep-1 cells through inhibition of p38 MAPK pathway,” Apoptosis, vol. 18, no. 12, pp. 1548–1560, 2013. View at: Publisher Site | Google Scholar
  19. H.-H. Kwak, I.-R. Kim, H.-J. Kim, B.-S. Park, and S.-B. Yu, “α -Mangostin induces apoptosis and cell cycle arrest in oral squamous cell carcinoma cell,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 5352412, 10 pages, 2016. View at: Publisher Site | Google Scholar
  20. R. Kalluri and R. A. Weinberg, “The basics of epithelial-mesenchymal transition,” The Journal of Clinical Investigation, vol. 119, no. 6, pp. 1420–1428, 2009. View at: Publisher Site | Google Scholar
  21. Z. Cheng, Y. Guo, Y. Yang et al., “Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway,” Oncology Reports, vol. 36, no. 2, pp. 1023–1029, 2016. View at: Publisher Site | Google Scholar
  22. S. Wang, D. Zhang, S. Han et al., “Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway,” Scientific Reports, vol. 7, no. 1, article 6215, 2017. View at: Publisher Site | Google Scholar
  23. P.-C. Hsu, Y.-T. Huang, M.-L. Tsai, Y.-J. Wang, J.-K. Lin, and M.-H. Pan, “Induction of apoptosis by shikonin through coordinative modulation of the Bcl-2 family, p27, and p53, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells,” Journal of Agricultural and Food Chemistry, vol. 52, no. 20, pp. 6330–6337, 2004. View at: Publisher Site | Google Scholar
  24. C.-C. Lu, J.-S. Yang, J.-H. Chiang et al., “Cell death caused by quinazolinone HMJ-38 challenge in oral carcinoma CAL 27 cells: dissections of endoplasmic reticulum stress, mitochondrial dysfunction and tumor xenografts,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1840, no. 7, pp. 2310–2320, 2014. View at: Publisher Site | Google Scholar
  25. J. Sun, X. Shi, S. Li, and F. Piao, “2,5-hexanedione induces bone marrow mesenchymal stem cell apoptosis via inhibition of Akt/Bad signal pathway,” Journal of Cellular Biochemistry, vol. 119, no. 4, pp. 3732–3743, 2018. View at: Publisher Site | Google Scholar
  26. L. Yang, T.-Q. Zha, X. He et al., “Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer,” Oncology Reports, vol. 39, no. 1, pp. 53–60, 2018. View at: Publisher Site | Google Scholar
  27. D. Lv, H. Wu, R. Xing et al., “HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways,” Oncotarget , vol. 8, no. 8, pp. 13586–13599, 2017. View at: Publisher Site | Google Scholar
  28. Y. Akao, Y. Nakagawa, M. Iinuma, and Y. Nozawa, “Anti-cancer effects of xanthones from pericarps of mangosteen,” International Journal of Molecular Sciences, vol. 9, no. 3, pp. 355–370, 2008. View at: Publisher Site | Google Scholar
  29. S. Beninati, S. Oliverio, M. Cordella et al., “Inhibition of cell proliferation, migration and invasion of B16-F10 melanoma cells by α-mangostin,” Biochemical and Biophysical Research Communications, vol. 450, no. 4, pp. 1512–1517, 2014. View at: Publisher Site | Google Scholar
  30. J. Yuan, Y. Wu, and G. Lu, “A-mangostin suppresses lipopolysaccharide-induced invasion by inhibiting matrix metalloproteinase-2/9 and increasing E-cadherin expression through extracellular signal-regulated kinase signaling in pancreatic cancer cells,” Oncology Letters, vol. 5, no. 6, pp. 1958–1964, 2013. View at: Publisher Site | Google Scholar
  31. Y.-W. Shih, S.-T. Chien, P.-S. Chen, J.-H. Lee, S.-H. Wu, and L.-T. Yin, “α-Mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via αvβ3 integrin/FAK/ERK and NF-κB signaling pathway in human lung adenocarcinoma A549 cells,” Cell Biochemistry and Biophysics, vol. 58, no. 1, pp. 31–44, 2010. View at: Publisher Site | Google Scholar
  32. N. Hail Jr., B. Z. Carter, M. Konopleva, and M. Andreeff, “Apoptosis effector mechanisms: a requiem performed in different keys,” Apoptosis, vol. 11, no. 6, pp. 889–904, 2006. View at: Publisher Site | Google Scholar
  33. J. Yang, C. Xu, H. Chen et al., “In vitro and in vivo antitumor effects of the diterpene-enriched extract from Taxodium ascendens through the mitochondrial-dependent apoptosis pathway,” Biomedicine & Pharmacotherapy, vol. 96, pp. 1199–1208, 2017. View at: Publisher Site | Google Scholar
  34. A. Letai, M. C. Bassik, L. D. Walensky, M. D. Sorcinelli, S. Weiler, and S. J. Korsmeyer, “Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics,” Cancer Cell, vol. 2, no. 3, pp. 183–192, 2002. View at: Publisher Site | Google Scholar
  35. T. Lin, X. Yin, Q. Cai et al., “13-Methyltetradecanoic acid induces mitochondrial-mediated apoptosis in human bladder cancer cells,” Urologic Oncology: Seminars and Original Investigations, vol. 30, no. 3, pp. 339–345, 2012. View at: Publisher Site | Google Scholar
  36. S. Kalimuthu and K. Se-Kwon, “Cell survival and apoptosis signaling as therapeutic target for cancer: marine bioactive compounds,” International Journal of Molecular Sciences, vol. 14, no. 2, pp. 2334–2354, 2013. View at: Publisher Site | Google Scholar
  37. N. Gavert and A. Ben-Ze'ev, “Epithelial-mesenchymal transition and the invasive potential of tumors,” Trends in Molecular Medicine, vol. 14, no. 5, pp. 199–209, 2008. View at: Publisher Site | Google Scholar
  38. G.-A. Lee, K.-A. Hwang, and K.-C. Choi, “Roles of dietary phytoestrogens on the regulation of epithelial-mesenchymal transition in diverse cancer metastasis,” Toxins, vol. 8, no. 6, article 162, 2016. View at: Publisher Site | Google Scholar
  39. S. Lamouille, J. Xu, and R. Derynck, “Molecular mechanisms of epithelial-mesenchymal transition,” Nature Reviews Molecular Cell Biology, vol. 15, no. 3, pp. 178–196, 2014. View at: Publisher Site | Google Scholar
  40. S. J. Serrano-Gomez, M. Maziveyi, and S. K. Alahari, “Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications,” Molecular Cancer, vol. 15, no. 1, article 18, 2016. View at: Publisher Site | Google Scholar
  41. L. Cui, W. Bu, J. Song et al., “Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway,” Archives of Pharmacal Research, vol. 41, no. 3, pp. 299–313, 2018. View at: Publisher Site | Google Scholar
  42. C. Zhang, T. Liu, G. Wang et al., “Rac3 regulates cell invasion, migration and EMT in lung adenocarcinoma through p38 MAPK pathway,” Journal of Cancer, vol. 8, no. 13, pp. 2511–2522, 2017. View at: Publisher Site | Google Scholar
  43. C.-M. Chen, S.-C. Hsieh, C.-L. Lin, Y.-S. Lin, J.-P. Tsai, and Y.-H. Hsieh, “Alpha-mangostin suppresses the metastasis of human renal carcinoma cells by targeting MEK/ERK expression and MMP-9 transcription activity,” Cellular Physiology and Biochemistry, vol. 44, no. 4, pp. 1460–1470, 2017. View at: Publisher Site | Google Scholar

Copyright © 2018 Sung-Jin Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

989 Views | 386 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder